Procalcitonin as a Marker of Severity of Non-cystic Fibrosis Bronchiectasis in Children

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-18
SponsorAssiut University

About this trial

The aim of this study is to evaluate the role of procalcitonin in bronchoalveolar lavage as a biomarker for assessment of severity of non-CF bronchiectasis in children in correlation with other markers (functional and radiological severity )

Eligibility criteria

Qualifiers

Children of both sex

Children aged from 6-17 years old.

Documented diagnosis of non-CF bronchiectasis by confirmed bronchiectasis findings using high-resolution computed tomographic (HRCT) lung scanning, and clinical symptoms consistent with bronchiectasis with a negative sweat test

Disqualifiers

Age less than 6 years or more than 17 years.

Children Diagnosed with cystic fibrosis bronchiectasis with confirmed positive sweat chloride test(6).

If there was a history of a recent exacerbation during the previous month preceding the study.

Trial design

Treatments tested in this trial

  • procalcitonin

Treatment groups

No treatment groups listed

Locations

This trial has no locations

Sponsors and collaborators